Oxidized low density lipoprotein inhibits inducible nitric oxide synthase, GTP cyclohydrolase I and transforming growth factor β gene expression in rat macrophages

Journal of Physiology and Pharmacology

Volumn 50, Issue 3, 1999, Pages 429-441

  Dulak, Józef ^a,b   Polus, M ^a   Guevara, I ^a   Hartwich, J ^a   Wybranska I ^a   Krzesz, R ^a   Dembińska Kieć, Aldona ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Atherosclerosis; GTP cyclohydrolase I; Inducible nitric oxide synthase; LDL; Nitric oxide; TGF

Indexed keywords

GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; LIPOPROTEIN METABOLISM; NONHUMAN; OXIDATION; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; RAT;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION; GTP CYCLOHYDROLASE; HUMANS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032850707     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
2. Wiztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
3. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963-20966.
4. Rosenfeld ME, Khoo JC, Miller E et al. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low density lipoproteins and contain oxidation-specific lipid-protein adducts. J Clin Invest 1991; 87: 90-99
5. Yates MT, Lambert LE, Whitten PJ et al. A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett 1992; 309: 135-138
6. Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarthy S. Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis. FEBS Lett 1993; 334: 170-174
7. Rubbo H, Parthasarthy S, Barnes S, Kirk M, Kalyanaraman B, Freeman B. Nitric oxide inhibition of lipooxygenease-dependent liposome and low density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch Biochem Biophys 1995; 324: 15-25
8. Cooke JP, Dzau VJ. Nitric oxide synthase; role in the genesis of vascular disease. Ann Rev Med 1997; 48: 489-509.
9. Boger RH, Bode-Boger SM, Frolich JC. The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis 1996; 127: 1-11.
10. Bossaller C, Habib GB, Yamamoto H, Wiliams C, Wells S, Henry PD. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest 1987; 79: 1701-74
11. Shimokawa H, Flavahan NA, Vanhoutte P. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 1991; 83: 652-660
12. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990; 86: 2109-2116.
13. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992; 89: 10-18.
14. Deckert V, Persegol L, Viens L et al. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins. Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 1997; 95: 723-731.
15. Liao JK, Shon WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319-324.
16. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.
17. Pritchard KA, Groszek L, Smalley DM et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995; 77: 510-518.
18. Wybrańska I, Miszczuk-Jamska B, Baczyńska E et al. Influence of SIN-1 and sodium nitrioprusside (NaNP) on ox-LDL metabolism in macrophages. J Physiol Pharmacol 1994; 45: 387-343.
19. Yang XC, Cai BL, Sciacca RR, Cannon PJ. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Circ Res 1994; 74: 318-328
20. Bolton EJ, Jessup W, Stanley KK, Dean RT. Enhanced LDL oxidation by murine macrophage foam cells and their failure to secrete nitric oxide. Atherosclerosis 1994; 106: 213-223.
21. Nathan C, Xie Q-W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269: 13725-137288.
22. Kwon NS, Nathan C, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 1989; 264: 20496-20501
23. 4B promotes assembly of enzyme subunits into an active dimer. Proc Natl Acad Sci USA 1995; 92: 11771 -11775.
24. Schoedon G, Troppmair J, Adolf G, Huber C, Niederwieser A. Interferon-gamma enhances biosynthesis of pterins in peripheral blood mononuclear cells by induction of GTP-cyclohydrolase I activity. J Interferon Res 1986; 6: 697-703.
25. Vodovotz Y, Bogdan C, Paik J, Xie Q-W, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J Exp Med 1993; 178: 605-613.
26. Perrella M, Yoshizumi M, Fen Z et al. Transforming growth factor-β1, but not dexamethasone, down regulates nitric-oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem 1994; 269: 14595-14600.
27. Perrella MA, Patterson C, Tan L et al. Suppression of interleukin-1β -induced nitric oxide synthase promoter/enhancer activity by transforming growth factor β1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-NB. J Biol Chem 1996; 271: 13776-13780.
28. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leuk Biol 1993; 54: 171-178.
29. Chomczyński P, Sacchi N. Single-step method of RNA isolation by acid guanidinum-thiocynate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
30. Polus M, Dulak J, Dembińska-Kieć A. Diminished expression of inducible nitric oxide synthase mRNA in rat vascular smooth muscle cells treated both with n-LDL and ox-LDL - application of quantitative PCR. Acta Angiologica 1997, 3;135-142.
31. Köhler T, Lassner D, Rost AK, Thamm B, Pustowoit B, Remke H. Quantitation of mRNA by polymerase chain reaction. Springer Verlag, Berlin Heidelberg 1995.
32. Dulak J., Funke H., Assmann G., Dembińska-Kieć A. 1996. Quantitative polymerase chain reaction in viral diagnostics - estimation of hepatitis C virus infection. Hepatol Polska, 3: 31-39.
33. Dulak J, Krzesz R, Polus M. et al. Inducible nitric oxide synthase (iNOS gene expression in rat cells studied by Northern blot hybridization and RT-PCR amplification. Acta Angiologica, 1996; 2: 57-64.
34. Guevara I, Iwanejko J, Dembińska-Kieć A et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction., Clin. Chim. Acta, 1998; 274: 177-188.
35. Scott-Burden T, Elizondo E, Ge T, Boulanger CM, Vanhoutte PM. Growth factor regulation of interleukin-1β induced nitric oxide synthase and GTP:cyclohydrolase expression in cultured smooth muscle cells. Biochem Biophys Res Commun 1993; 196: 1261-1266
36. Buttery LDK, Springall DR, Chester AH et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest 1996; 75: 77-85
37. Wilcox JN, Subramanian RR, Sundell CL et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arteriosler Thromb Vasc Biol 1997; 17: 2479-2488
38. Luoma JS, Stralin P, Marklund SL, Hiltunen TP, Sarkioja T, Yla-Hertualla S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol 1998; 18: 157-167.
39. Huk I, Nanobashvili J, Nummayer C et al. L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 1997; 95: 667-675.
40. Schmidt K, Werner ER, Mayer B, Wachter H, Kukovetz WR. Tetrahydrobiopterin-dependent formation of endothelium-derived relaxing factor (nitric oxide) in aortic endothelial cells. Biochem J 1992; 281: 297-300.
41. Gross SS, Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle cells. J Biol Chem 1992; 267: 25722-25729.
42. Rosenkranz-Weiss P, Sessa WC, Milstein S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. J Clin Invest 1994; 93: 2236-2243.
43. Van Amsterdam JGC, Wemer J. Tetrahydrobiopterin induces vasodilation via enhancement of cGMP level. Eur J Pharmacol 1992; 215: 349-350.
44. Stroes E, Kastelein J, Cosentino F et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99: 41-46.
45. Grainger DJ, Kemp PR, Metcalf JC et al. The serum concentration of active transforming growth factor beta is severly depressed in advanced atherosclerosis. Nat Med 1995; 1: 74-79.
46. Xie Q-W, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705-4708.
47. Eberhardt W, Kunz D, Hummel R, Pfeilschifter J. Molecular cloning of the rat inducible nitric oxide synthase gene promoter. Biochem Biophys Res Commun. 1996; 223; 752-756.
48. Hattori Y, Nakanishi N, Kasai K. Role of nuclear factor kappa B in cytokine-induced nitric oxide and tetrahydrobiopterin synthesis in rat neonatal cardiac myocytes. J Mol Cell Cardiol 1997; 29: 1585-1592.
49. Ohlsson BG, Englund MCO, Karlsson A-LK et al. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-NB to DNA and subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest 1996; 98: 78-89.
50. Shackleford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO. Oxidized low density lipoprotein suppresses activation of NF-NB in macrophages via pertussis toxin-sensitive signalling mechanism. J Biol Chem 1995; 270: 3475-3478.
51. Brand K, Eisele T, Kreusel U et al. Dysregulation of monocytic nuclear factor-NB by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol 1997; 17: 1901-1909
52. Nagy L, Tonotoz P, Alvarez JGA, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ. Cell 1998; 93: 229-240.
53. Tonotoz P, Nagy L, Alvarez JGA, Thomazy VA, Evans RM. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-252.
54. Jiang C, Ting AT, Seed B. PPARγ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
55. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage function. Nature 1998, 391: 79-82.
56. Bereta J, Bereta M. Stimulation of glyceraldehyde - 3-phosphate dehydrogenase mRNA levels by endogenous nitric oxide in cytokine-activated endothelium. Biochem Biophys Res Commun 1995; 217: 363-369.